TY - JOUR TI - NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib AU - Chen, Zheng AU - Wei, Xiangyu AU - Wang, Xueyi AU - Zheng, Xuan AU - Chang, Bowen AU - Shen, Lin AU - Zhu, Hanshuo AU - Yang, Min AU - Li, Shiting AU - Zheng, Xuesheng T2 - Cell Death & Disease AB - NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, 4-like 2 (NDUFA4L2) is a subunit of Complex I of the mitochondrial respiratory chain, which is important in metabolic reprogramming and oxidative stress in multiple cancers. However, the biological role and molecular regulation of NDUFA4L2 in glioblastoma (GBM) are poorly understood. Here, we found that NDUFA4L2 was significantly upregulated in GBM; the elevated levels were correlated with reduced patient survival. Gene knockdown of NDUFA4L2 inhibited tumor cell proliferation and enhanced apoptosis, while tumor cells initiated protective mitophagy in vitro and in vivo. We used lentivirus to reduce expression levels of NDUFA4L2 protein in GBM cells exposed to mitophagy blockers, which led to a significant enhancement of tumor cell apoptosis in vitro and inhibited the development of xenografted tumors in vivo. In contrast to other tumor types, NDUFA4L2 expression in GBM may not be directly regulated by hypoxia-inducible factor (HIF)-1α, because HIF-1α inhibitors failed to inhibit NDUFA4L2 in GBM. Apatinib was able to effectively target NDUFA4L2 in GBM, presenting an alternative to the use of lentiviruses, which currently cannot be used in humans. Taken together, our data suggest the use of NDUFA4L2 as a potential therapeutic target in GBM and demonstrate a practical treatment approach. DA - 2021/04/07/ PY - 2021 DO - 10.1038/s41419-021-03646-3 DP - www.nature.com VL - 12 IS - 4 SP - 1 EP - 15 LA - en SN - 2041-4889 UR - https://www.nature.com/articles/s41419-021-03646-3 Y2 - 2021/04/07/17:02:36 ER -